rare cancer | sciencenewsnet.in

Breaking News

Daniel B.F. Saris, MD, PhD, Receives the First Arnold I. Caplan Award for Distinguished Research in Orthobiologics

Wildfire smoke can carry toxins hundreds of kilometres, depositing grime on urban structures, surfaces: research

Los Alamos National Laboratory partners with OpenAI to advance national security

Friedman School Receives Historic $10 Million Gift for Financial Aid

Astronomers Detect Missing Ingredient in Cooking Up Stars

Researchers examine economic impacts of aquatic dead zones

UA Little Rock Awarded $750,000 Cybersecurity Training Grant

Happiness expert available: Case Western Reserve University researcher gives tips for how to build resilience, motivation and well-being in a time of crisis

MyOme and Novi Health Collaborate to Bring Whole Genome Testing to Employer Health Programs

Grossman wins 2025 Transatlantic Alliance Award in Endocrinology

30 Jan, 2025

ASH 2024: Antibody Shows Encouraging Results for Treating High-risk Follicular Lymphoma and Marginal Zone Lymphoma

December 8, 2024 sarah JonasResearch Results

ASH 2024 Presentations: Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and marginal zone lymphoma.

A vision for rare cancer research: $5 million commitment launches CURE, a rare cancer initiative, at Case Comprehensive Cancer Center

September 29, 2023 sarah JonasFeature

The CURE initiative aims to build on Case CCC’s collaborative nature to create a national network among U.S. cancer centers, and to catalyze innovative bench-to-bedside approaches to identifying and treating rare cancers.